Trial intelligence / Profile preview

Triple antibiotic vs chlorhexidine irrigation in breast reconstruction

NCT02395614Completed

Sponsor
Vanderbilt University Medical Center
Start
Dec 2015
Primary completion
Dec 2020
Modality
Small Molecules
Countries
1
01

Overview

Randomised, open-label trial of chlorhexidine in surgical site infection (SSI), sponsored by Vanderbilt University Medical Center. Primary endpoint: Surgical Site Infection at 6 months. Started Dec 2015; status: completed.

02

Drugs

chlorhexidine
03

Conditions

surgical site infection (SSI)

Beyond the preview

Go deeper on NCT02395614.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02395614.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call